Evidence map›Paper›PMID 28651522›Full record

ArticleBMC infectious diseases2017

The role of Enterococcus spp. and multidrug-resistant bacteria causing pyogenic liver abscesses.

Marcus M Mücke, Johanna Kessel, Victoria T Mücke, Katharina Schwarzkopf, Michael Hogardt, Christoph Stephan, Stefan Zeuzem, Volkhard A J Kempf, Christian M Lange

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06852235 (Characteristics and Treatment Outcome of Liver Abscesses), which is not on this map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06852235 not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Characteristics and Treatment Outcome of Liver Abscesses: An Observational Study

TypeobservationalSponsorAssiut UniversityRan2025 to 2027Enrolled70ConditionsLiver Abscess
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Marcus M MückeDepartment of Internal Medicine 1, University Hospital Frankfurt, Frankfurt am Main, Germany.ORCID 0000-0001-8475-8369
Johanna KesselUniversity Center for Infectious Diseases, University Hospital Frankfurt, Frankfurt am Main, Germany.
Victoria T MückeDepartment of Internal Medicine 1, University Hospital Frankfurt, Frankfurt am Main, Germany.
Katharina SchwarzkopfDepartment of Internal Medicine 1, University Hospital Frankfurt, Frankfurt am Main, Germany.
Michael HogardtUniversity Center for Infectious Diseases, University Hospital Frankfurt, Frankfurt am Main, Germany.
Christoph StephanUniversity Center for Infectious Diseases, University Hospital Frankfurt, Frankfurt am Main, Germany.
Stefan ZeuzemDepartment of Internal Medicine 1, University Hospital Frankfurt, Frankfurt am Main, Germany.
Volkhard A J KempfUniversity Center for Infectious Diseases, University Hospital Frankfurt, Frankfurt am Main, Germany.
Christian M LangeDepartment of Internal Medicine 1, University Hospital Frankfurt, Frankfurt am Main, Germany. Christian.Lange@kgu.de.
Goethe University Frankfurt · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPyogenic liver abscesses (PLA) remain a significant clinical problem. Unfortunately, little is known about current bacterial susceptibility profiles and the incidence of multidrug resistant organisms (MDROs) causing PLA in Western countries. Yet, this crucial information is pivotal to guide empirical antibiotic therapy. Aim of this study was to provide detailed characteristics of PLA with a special focus on underlying bacterial pathogens and their susceptibility to antibiotics.

methodsA retrospective study of patients diagnosed with PLA from 2009 to 2015 in a large tertiary reference center in Germany was performed in order to characterize PLA and antimicrobial susceptibility profiles of causative bacterial species.

resultsOverall, 86 patients were included. The most common causes of PLA were bile duct stenosis/obstruction (31.4%) and leakage of biliary anastomosis (15.1%). Frequent predisposing diseases were malignancies (34.9%), diabetes (24.4%) and the presence of liver cirrhosis (16.3%). Of note, Enterococcus spp. were the most frequently cultured bacterial isolates (28.9%), and in 1/3 of cases vancomycin resistance was observed. In addition, a relevant frequency of gram-negative MDROs was identified. In particular, an alarming 10% and 20% of gram-negative bacteria were resistant to carbapenems and tigecycline, respectively. Of note, MDRO status did not predict ICU stay or survival in multivariate regression analysis. The mortality rate in our series was 16.3%.

conclusionOur study demonstrates an as yet underreported role of Enterococcus spp., often associated with vancomycin resistance, as well as of gram-negative MDROs causing PLA.

Indexed as

AgedAnti-Bacterial AgentsCarbapenemsDrug Resistance, Multiple, BacterialEnterococcusFemaleGermanyGram-Negative BacteriaHumansLiver Abscess, PyogenicMaleMicrobial Sensitivity TestsMiddle AgedMinocyclineRetrospective StudiesTigecyclineAnti-Bacterial AgentsCarbapenemsMinocyclineTigecyclineBacterial pathogensMultidrug-resistant organismsPyogenic liver abscessSusceptibility profilesVancomycin-resistant enterococci

Identifiers

PMID28651522
PMCPMC5485679
OpenAlexW2675104011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.